Givopegsomatropin

金培生长激素

Report date: 2025/11/10 17:51:51

Base Information

Drug NameGivopegsomatropin
Drug Alias Name聚乙二醇重组人生长激素PEG-somatropinPEG-GHPEG-rhGHPolyethylene glycol recombinant human somatropin +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders +[5] 
Global Approved IndicationsGrowth hormone deficiencyGrowth Disorders
Approved Indications in ChinaGrowth hormone deficiencyGrowth Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date2014/01/06
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChangchun GeneScience Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyIdiopathic short statureGrowth Disorders +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeH01AC01
Related LinksWikipediaDrugBankKEGG